MMSI - メリット・メディカル・システムズ (Merit Medical Systems Inc.) メリット・メディカル・システムズ

 MMSIのチャート


 MMSIの企業情報

symbol MMSI
会社名 Merit Medical Systems Inc. (メリット・メディカル・システムズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Medical/Dental Instruments  
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 メリット・メディカル・システムズ(Merit Medical Systems Inc.)は各種の介入・診断・治療手順用使い捨て医療機器の製造・販売を行う。同社は心臓血管事業と内視鏡検査事業の2つの事業を運営する。心臓血管事業は冠状動脈疾病、末梢血管疾病及び他の非血管性疾病の診断・治療を支持する心臓学と放射線装置、並びに塞栓治療、心臓リズム管理(CRM)、電気生理学(EP)および介入腫瘍治療および スパインデバイスを含む。内視鏡検査事業は悪性腫瘍に原因する食道の拡大、気管と気管支・胆汁狭窄の緩和治療を支持する胃腸病学と肺臓学医療装置を提供する。同社は末梢介入、心臓介入、介入腫瘍学と脊柱、内視鏡検査という4つの製品グループに焦点を当てた製品を提供する。   メリット・メディカル・システムズは、米国の医療機器製造業者。診断で使用する医療機器の開発、製造、販売を行う。心臓病・放射線学分野にて冠動脈疾患、末梢血管疾患の診断と治療に塞栓術療法の製品を提供。また消化器・呼吸器分野にて悪性腫瘍に起因する食道・気管気管支・胆道狭窄の拡大の緩和治療に使う内視鏡などの医療機器を手掛ける。   Merit Medical Systems, Inc. engages in the manufacture and marketing of proprietary disposable medical devices. It operates through the Cardiovascular and Endoscopy segments. The Cardiovascular segment consists of peripheral intervention, cardiac intervention, interventional oncology and spine, and cardiovascular and critical care product groups. The Endoscopy segment integrates non-vascular stent technology with balloon dilators, inflation devices, guide wires, procedure kits, and other devices that are used by gastroenterologists, endoscopists, pulmonologists, and thoracic and general surgeons. The company was founded by Fred P. Lampropoulos, Darla Gill, Kent W. Stanger, and William Padilla in July 1987 and is headquartered in South Jordan, UT.
本社所在地 1600 West Merit Parkway South Jordan UT 84095 USA
代表者氏名 Fred P. Lampropoulos フレッドP.ランポロプロス
代表者役職名 Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者(CEO)
電話番号 +1 801-253-1600
設立年月日 31959
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 4876人
url www.merit.com
nasdaq_url https://www.nasdaq.com/symbol/mmsi
adr_tso
EBITDA EBITDA(百万ドル) 99.64400
終値(lastsale) 64.12
時価総額(marketcap) 3509639362.32
時価総額 時価総額(百万ドル) 3433.01
売上高 売上高(百万ドル) 798.07900
企業価値(EV) 企業価値(EV)(百万ドル) 3803.065
当期純利益 当期純利益(百万ドル) 21.64700
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Merit Medical Systems Inc. revenues increased 20% to $427.8M. Net income decreased 33% to $16.2M. Revenues reflect Cardiovascular segment increase of 20% to $412.2M Endoscopy segment increase of 19% to $15.6M. Basic Earnings per Share excluding Extraordinary Items decreased from $0.52 to $0.32.

 MMSIのテクニカル分析


 MMSIのニュース

   Merit Medical (MMSI) Up 18.4% Since Last Earnings Report: Can It Continue?  2020/05/23 15:30:39 Zacks Investment Research
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Here's Why You Should Retain Merit Medical (MMSI) for Now  2020/05/20 03:15:00 Zacks Investment Research
Investor confidence is high in Merit Medical (MMSI) stock, thanks to solid prospects.
   Shareholder Alert: Robbins LLP Announces It Is Investigating Merit Medical Systems, Inc. (MMSI) for Misleading Shareholders  2020/05/07 23:13:00 Business Wire
SAN DIEGO & SOUTH JORDAN, Utah--(BUSINESS WIRE)---- $MMSI #ClassAction--Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics. If you suffered a loss as a result of Merit's misconduct, click
   Shareholder Alert: Robbins LLP Reminds Investors Merit Medical Systems, Inc. (MMSI) Sued for Misleading Shareholders  2020/04/14 22:32:00 Business Wire
SAN DIEGO & SOUTH JORDAN, Utah--(BUSINESS WIRE)---- $MMSI #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Merit Medical Systems, Inc. (NASDAQ: MMSI) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between February 26, 2019 and October 30, 2019. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics. If you suffered a loss as a result of Merit's misconduct, click here. Merit Medi
   Merit Medical WRAPSODY Gets 2 FDA Breakthrough Device Nods  2020/04/07 06:15:00 Zacks Investment Research
This regulatory clearance is expected to bolster Merit Medical Systems' (MMSI) cardiovascular segment.
   Shareholder Alert: Robbins LLP Announces It Is Investigating Merit Medical Systems, Inc. (MMSI) for Misleading Shareholders  2020/05/07 23:13:00 Business Wire
SAN DIEGO & SOUTH JORDAN, Utah--(BUSINESS WIRE)---- $MMSI #ClassAction--Shareholder rights law firm Robbins LLP announces that it is investigating Merit Medical Systems, Inc. (NASDAQ: MMSI) for alleged violations of the Securities Exchange Act of 1934 and whether the Company's officers and directors breached their fiduciary duties to shareholders. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics. If you suffered a loss as a result of Merit's misconduct, click
   Shareholder Alert: Robbins LLP Reminds Investors Merit Medical Systems, Inc. (MMSI) Sued for Misleading Shareholders  2020/04/14 22:32:00 Business Wire
SAN DIEGO & SOUTH JORDAN, Utah--(BUSINESS WIRE)---- $MMSI #ClassAction--Shareholder rights law firm Robbins LLP reminds investors that a purchaser of Merit Medical Systems, Inc. (NASDAQ: MMSI) filed a class action complaint for alleged violations of the Securities Exchange Act of 1934 between February 26, 2019 and October 30, 2019. Merit manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutics. If you suffered a loss as a result of Merit's misconduct, click here. Merit Medi
   Merit Medical WRAPSODY Gets 2 FDA Breakthrough Device Nods  2020/04/07 06:15:00 Zacks Investment Research
This regulatory clearance is expected to bolster Merit Medical Systems' (MMSI) cardiovascular segment.
   Merit Medical (MMSI) Down 24.4% Since Last Earnings Report: Can It Rebound?  2020/03/25 15:30:26 Zacks Investment Research
Merit Medical (MMSI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
   Here's Why You Should Retain Merit Medical (MMSI) Stock Now  2020/03/24 08:55:00 Zacks Investment Research
Merit Medical (MMSI) continues to benefit from growing product pipeline, strong R&D focus and strategic acquisitions.
   Analysts Estimate Merit Medical (MMSI) to Report a Decline in Earnings: What to Look Out for  2020/02/17 17:30:47 Zacks Investment Research
Merit Medical (MMSI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
   Merit Medical Class Action Reminder: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Merit Medical Systems, Inc. To Contact The Firm  2020/01/31 18:16:00 NewMediaWire
NEW YORK, NY - (NewMediaWire) - January 31, 2020 - Faruqi (2) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during FY19; and (3) in light of the foregoing, the Company’s reported financial guidance for FY19 and FY20 was made without a reasonable basis On July 26, 2019, Morningstar issued an analyst report, titled “Merit’s 2Q Miss Poised to Reset Investor Expectations; Reiterate Our Overvalued Call,” which noted that while the FY20 growth forecast was maintained, it was based on a smaller base and thus was actually a reduction. On this news, the Company's stock price fell from $54.84 per share on July 25, 2019 to $41.00 per share on July 26, 2019: a $13.84 or 25.24% drop. Then, on October 30, 2019, Piper Jaffray issued an analyst report on Merit, titled “Another Shoe Drops Here in Q3; Sticking with OW,” which discussed the “Disappointing Q3 Results,” which were primarily attributable to the Company’s acquisitions, and reduced its price target to $30.00 from $40.00.
   DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Merit Medical Systems, Inc. and Reminds Investors to Contact the Firm  2020/01/31 17:00:00 Business Wire
NEW YORK--(BUSINESS WIRE)-- #classaction--Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of investors that purchased Merit Medical Systems, Inc. (NASDAQ: MMSI) securities between February 26, 2019 and October 30, 2019 (the “Class Period”). Investors have until February 3, 2020 to apply to the Court to be appointed as lead plaintiff in
   Merit Medical : Additional proxy soliciting materials - definitive | MarketScreener  2020/01/28 16:35:06 MarketScreener
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A INFORMATION … | January 28, 2020
   Merit Medical : Annual filing director officer or owner of more than ten percent. | MarketScreener  2020/01/23 22:20:07 MarketScreener
SEC Form 5 FORM 5 Check this box if no longer subject to Section 16. Form 4 or Form 5… | January 23, 2020

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 メリット・メディカル・システムズ MMSI Merit Medical Systems Inc.)

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)